We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Urea and Creatinine Stability Determined for Chemistry Analyzer

By LabMedica International staff writers
Posted on 17 Dec 2013
Print article
Advia 1800 Chemistry Analyzer System (Photo courtesy of Siemens).
Advia 1800 Chemistry Analyzer System (Photo courtesy of Siemens).
Serum creatinine values of patients tend to change as a result of the use of different blanks used for creatinine determinations on some clinical chemistry analyzers.

A general quality assurance program in clinical chemistry laboratories is an essential part of monitoring the stabilities of determinations on what are commonly known as stat analytes, including sodium, potassium, chloride, bicarbonate, calcium, glucose, blood urea nitrogen (BUN), and creatinine.

Medical laboratory scientists at the New York Harbor Veteran Affairs Medical Center (Brooklyn, NY, USA) investigated the reproducibility of creatinine values, by determining the serial creatinine values in the sera of 13 patients whose initial values were either in the reference range or elevated (range 0.58 to 7.8 mg/dL). They determined BUN and creatinine values, using the glutamate dehydrogenase linked enzyme assay system and the Jaffe method, respectively.

Determination of all values was performed on the Siemens Advia 1800 chemistry analyzer (Siemens Healthcare; Tarrytown, NY, USA) using the method for creatinine, which uses the formation of a complex of creatinine with picric acid, and for BUN values urease-catalyzed release of ammonia was measured by the glutamate dehydrogenase system. The creatinine values were determined concurrently with serum blood urea nitrogen (BUN) determinations, range 6.0 to 84.4 mg/dL, as these two analytes are used together in evaluation of renal function.

The scientists found that all values for creatinine on samples stored at 4 °C were reproducible as were the corresponding BUN values, which is revealed by low values for the coefficients of variation (CV). One sample with relatively high CV of 10.6% for creatinine was found to have an initial value of 1.1 mg/dL, in the reference range; but, on repeat determinations, the obtained levels were as high as 1.5 mg/dL, above the reference range. BUN values for this sample remained in the reference range, suggesting that no renal disease was present.

The authors concluded that the precision of the serum BUN assays on the Advia 1800 analyzer is quite high over the prolonged time period of 15 days. The same conclusion applies to serum creatinine assay results on this analyzer with the caveat that borderline values can show less precision-making evaluation of renal function more difficult. The study was published on November 11, 2013, in the Journal of Clinical Laboratory Analysis.

Related Links:

New York Harbor Veteran Affairs Medical Center
Siemens Healthcare
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more